Related Experiment Video
Updated: Sep 19, 2025

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
Highlights of 2024: unleashing the power of NK cells-cancer's worst nightmare
Capucine Bourel1,2, Fernando Souza-Fonseca-Guimaraes3, Sylvie Lesage1,2
1Immunologie-oncologie, Centre de recherche de l'Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.
Abstract:
In this article for the Highlights of 2024 Series, we discuss strategies to enhance NK cell-based cancer therapies. These include (1) cytokine expression on bacterial membranes to boost NK cell activation in tumors, (2) optimizing CAR-NK cell manufacturing for improved efficacy, (3) using CRISPR-Cas9 to identify and target inhibitory genes, and (4) using tetraspecific engagers to enhance cytotoxicity and cytokine memory-like NK cells strengthening anti-tumor responses. This year's progress holds much promise for cancer treatments exploiting NK cells.
Insights
Strategies to enhance natural killer (NK) cell cancer therapies are discussed, including bacterial cytokine expression, CAR-NK cell optimization, CRISPR-Cas9 gene targeting, and tetraspecific engagers for improved anti-tumor responses.
Area of Science:
- Immunology
- Cancer Therapy
- Cellular Engineering
Background:
- Natural killer (NK) cells are crucial for innate immunity against cancer.
- Enhancing NK cell activity is a promising strategy for novel cancer treatments.
- Current NK cell therapies face challenges in efficacy and manufacturing.
Purpose of the Study:
- To review recent advancements in NK cell-based cancer therapies.
- To highlight innovative strategies for boosting NK cell anti-tumor functions.
- To discuss the potential of these strategies in clinical applications.
Main Methods:
- Engineering bacterial membranes for cytokine delivery to tumors.
- Optimizing chimeric antigen receptor (CAR)-NK cell manufacturing processes.
- Utilizing CRISPR-Cas9 gene editing to modulate NK cell activity.
- Developing tetraspecific engagers for enhanced NK cell cytotoxicity.
Main Results:
- Bacterial cytokine expression can significantly enhance NK cell activation within tumors.
- Optimized CAR-NK cell manufacturing improves therapeutic efficacy.
- CRISPR-Cas9 facilitates the identification and targeting of inhibitory NK cell genes.
- Tetraspecific engagers and cytokine memory-like NK cells strengthen anti-tumor immune responses.
Conclusions:
- Significant progress in 2024 offers new avenues for NK cell-based cancer treatments.
- These strategies collectively promise to improve the effectiveness of cancer immunotherapies.
- Further research and development are expected to translate these findings into clinical benefits.
Related Concept Videos
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...

